| Literature DB >> 27212838 |
Gunjan Mishra1, Vivek Ananth1, Kalpesh Shelke2, Deepak Sehgal1, Jayaraman Deepak1.
Abstract
Hepatitis is an emerging global threat to public health due to associated mortality, morbidity, cancer and HIV co-infection. Available diagnostics and therapeutics are inadequate to intercept the course and transmission of the disease. Antimicrobial peptides (AMP) are widely studied and broad-spectrum host defense peptides are investigated as a targeted anti-viral. Therefore, it is of interest to describe the supervised identification of anti-hepatitis peptides. We used a hybrid Support Vector Machine (SVM) with Ant Colony Optimization (ACO) algorithm for simultaneous classification and domain feature selection. The described model shows a 10 fold cross-validation accuracy of 94 percent. This is a reliable and a useful tool for the prediction and identification of hepatitis specific drug activity.Entities:
Year: 2016 PMID: 27212838 PMCID: PMC4857459 DOI: 10.6026/97320630012012
Source DB: PubMed Journal: Bioinformation ISSN: 0973-2063
Comparison of the results between SVM algorithms.
| No | Feature Subset | 10 fold Cross-Validation Accuracy using SVM algorithms (%) | |
| Hybrid ACO-infogain | Infogain | ||
| 1 | 500 | 93.3 | 92.8 |
| 2 | 450 | 94.0 | 91.9 |
| 3 | 400 | 93.5 | 91.8 |
| 4 | 350 | 93.0 | 91.1 |
| 5 | 300 | 92.9 | 91.0 |
Figure 1Plot of the respective descriptor prediction of the model.